Last reviewed · How we verify
NCT05113628
Methylene Blue Spray for Identification of Recurrent Laryngeal Nerve and Parathyroid Gland
NA trial testing methylene blue identification in Methylene Blue in 80 participants. Completed in 15 July 2021.
10 June 2021
Quick facts
| Lead sponsor | Zagazig University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 80 |
| Start date | 15 January 2020 |
| Primary completion | 10 June 2021 |
| Estimated completion | 15 July 2021 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- methylene blue identification
Conditions studied
- Methylene Blue — all drugs for Methylene Blue →
- Recurrent Laryngeal Nerve Injuries — all drugs for Recurrent Laryngeal Nerve Injuries →
- Parathyroid Gland — all drugs for Parathyroid Gland →
Sponsor
Zagazig University
Who can join
16 and older, any sex, with Methylene Blue or Recurrent Laryngeal Nerve Injuries. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Thyroidectomy is the procedure by which surgeons treat various thyroid diseases and is considered the commonest endocrinal surgery. Yet, it carries a risk for intraoperative complications. The most distressing complications are recurrent laryngeal nerve and parathyroid injuries. Methylene blue spray is a technique than can be used for easy identification of both recurrent laryngeal nerve and parathyroid glands so we can avoid their injuries.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05113628
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Methylene Blue
Currently open trials in the same condition.
- NCT06481410 — Efficacy and Safety of Methylene Blue in the Treatment of Severe Septic Shock · NA · recruiting
- NCT05830630 — Perineural Methylene Blue Infusion in Lower Limb Amputation Surgery · NA · recruiting
Other Zagazig University trials
Trials by the same sponsor.
- NCT07423676 — Comparison Between Two Drugs in Sedation of Upper GI Endoscopy · not yet recruiting
- NCT07418307 — Comparison Between Combined Biceps Femoris Short Head Block and Adductor Canal Block Versus Genicular Nerve Block · NA · not yet recruiting
- NCT07435025 — Surgery for Obstructed Gastric Carcinoma · NA · active not recruiting
- NCT07330375 — Effect of Intravenous Dexmedetomidine and Ketamine on Post-Operative Analgesia · Phase 3 · not yet recruiting
- NCT07309731 — Impact OF Cooled Versus Thermal Radiofrequency Denervation In Management Of Chronic Lumber Facet Joint Pain · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05113628 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zagazig University
- Last refreshed: 9 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05113628.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing